	Le Coût Des Ventes		Date
AbbVie	USD 4.55B	757M	2025-12
Acadia Pharmaceuticals	USD 21.65M	913K	2025-09
Akebia Therapeutics	USD 8.13M	2.41M	2025-03
ALKERMES	USD 51.59M	2.13M	2025-09
Alnylam Pharmaceuticals	USD 200.15M	57.2M	2025-09
Amarin	USD 16.89M	18.51M	2025-03
Amgen	USD 1.79B	128M	2025-12
Baxter International	USD 1.88B	66M	2025-09
Biogen	USD 810.1M	205.1M	2025-09
BioMarin Pharmaceutical	USD 144.93M	10M	2025-09
Bristol-Myers Squibb	USD 4.92B	657M	2025-12
Coherus Biosciences	USD 2.65M	31.2M	2025-03
Eli Lilly	USD 3.37B	363.7M	2025-12
Fujifilm	JPY 509.85B	19.73B	2025-12
Gilead Sciences	USD 1.57B	68M	2025-09
Ironwood Pharmaceuticals	USD 29.83M	560K	2024-09
Merck	USD 3.32B	531M	2025-12
Myriad Genetics	USD 61.9M	600K	2025-09
Pacira	USD 48.6M	6.59M	2025-09
Perrigo	USD 666.2M	27.2M	2025-09
Pfizer	USD 6.29B	2.12B	2025-12
PTC Therapeutics	USD 23.32M	7.83M	2025-09
Regeneron Pharmaceuticals	USD 584.6M	63M	2025-12
Sarepta Therapeutics	USD 151.45M	1.77M	2025-09
Teva Pharmaceutical Industries	USD 2.06B	120M	2025-12
Vertex Pharmaceuticals	USD 414.8M	7.3M	2025-09
Xencor	USD 61.66M	50.95M	2025-06
Zoetis	USD 683M	3M	2025-09

Coherus Biosciences Le Coût Des Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.